Aceneuramic Acid Extended-Release
UX001-CL203
Phase 2 small_molecule terminated
Quick answer
Aceneuramic Acid Extended-Release for Hereditary Inclusion Body Myopathy is a Phase 2 program (small_molecule) at Ultragenyx UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx UK Limited
- Indication
- Hereditary Inclusion Body Myopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated